# A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

> **NCT01430507** · PHASE2 · COMPLETED · sponsor: **Glenmark Pharmaceuticals Ltd. India** · enrollment: 406 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Revamilast
- **DRUG:** Revamilast
- **DRUG:** Revamilast
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01430507
- **Lead sponsor:** Glenmark Pharmaceuticals Ltd. India
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2012-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430507, "A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01430507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*